SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Y.-T. Li, H.-F. Cai, Z.-L. Zhang, Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials, Osteoporosis International, 2015, 26, 2, 431

    CrossRef

  2. 2
    Toni-Karri Pakarinen, Heikki-Jussi Laine, Heikki Mäenpää, Mika Kähönen, Pentti Mattila, Jorma Lahtela, Effect of immobilization, off-loading and zoledronic acid on bone mineral density in patients with acute Charcot neuroarthropathy: A prospective randomized trial, Foot and Ankle Surgery, 2013, 19, 2, 121

    CrossRef

  3. 3
    Julie LI-YU, Emmanuel C. PEREZ, Arturo CAÑETE, Lauro BONIFACIO, Lyndon Q. LLAMADO, Romil MARTINEZ, Allan LANZON, Mae SISON, Consensus statements on osteoporosis diagnosis, prevention, and management in the Philippines, International Journal of Rheumatic Diseases, 2011, 14, 3
  4. 4
    Leila Kolios, Ann Kristin Hoerster, Stephan Sehmisch, Marie Christin Malcherek, Thomas Rack, Mohammed Tezval, Dana Seidlova-Wuttke, Wolfgang Wuttke, Klaus Michael Stuermer, Ewa Klara Stuermer, Do Estrogen and Alendronate Improve Metaphyseal Fracture Healing When Applied as Osteoporosis Prophylaxis?, Calcified Tissue International, 2010, 86, 1, 23

    CrossRef

  5. 5
    Kyu-Tae Hwang, Byeong-Wook Yoo, Yee-Suk Kim, Il-Yong Choi, Young-Ho Kim, Persistency and Change of the Bone Mineral Density with Alendronate Treatment after Hip Fracture, The Journal of the Korean Hip Society, 2010, 22, 4, 312

    CrossRef

  6. 6
    Peter Augat, Lutz Claes, Increased cortical remodeling after osteotomy causes posttraumatic osteopenia, Bone, 2008, 43, 3, 539

    CrossRef

  7. 7
    June Hart Romeo, Juan Ybarra, Hypogonadal Hypogonadism and Osteoporosis in Men, Nursing Clinics of North America, 2007, 42, 1, 87

    CrossRef

  8. 8
    Ville-Valtteri Välimäki, Niko Moritz, Jessica J. Yrjans, Eero Vuorio, Hannu T. Aro, Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute, Bone, 2006, 38, 3, 432

    CrossRef

  9. 9
    T. Armingeat, R. Brondino, T. Pham, V. Legré, P. Lafforgue, Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study, Osteoporosis International, 2006, 17, 11, 1659

    CrossRef

  10. 10
    Uri A Liberman, Long-Term Safety of Bisphosphonate Therapy for Osteoporosis, Drugs & Aging, 2006, 23, 4, 289

    CrossRef

  11. 11
    Anna M. Sawka, Lehana Thabane, Alexandra Papaioannou, Amiram Gafni, David A. Hanley, Jonathan D. Adachi, A Systematic Review of the Effect of Alendronate on Bone Mineral Density in Men, Journal of Clinical Densitometry, 2005, 8, 1, 7

    CrossRef

  12. 12
    Jennifer J Kelly, Arnold M Moses, Osteoporosis in men: the role of testosterone and other sex-related factors, Current Opinion in Endocrinology & Diabetes, 2005, 12, 6, 452

    CrossRef

  13. 13
    Ryosuke Inoue, Nori-aki Matsuki, Gao Jing, Takashi Kanematsu, Kihachiro Abe, Masato Hirata, The inhibitory effect of alendronate, a nitrogen-containing bisphosphonate on the PI3K–Akt–NFκB pathway in osteosarcoma cells, British Journal of Pharmacology, 2005, 146, 5
  14. 14
    Gideon Rodan, Alfred Reszka, Ellis Golub, René Rizzoli, Bone safety of long-term bisphosphonate treatment, Current Medical Research and Opinion, 2004, 20, 8, 1291

    CrossRef

  15. 15
    Craig FJ Munns, Frank Rauch, Leonid Zeitlin, François Fassier, Francis H Glorieux, Delayed Osteotomy but Not Fracture Healing in Pediatric Osteogenesis Imperfecta Patients Receiving Pamidronate, Journal of Bone and Mineral Research, 2004, 19, 11
  16. 16
    Yvonne Zehnder, Simone Risi, Dieter Michel, Hans Knecht, Romain Perrelet, Marius Kraenzlin, Guido A Zäch, Kurt Lippuner, Prevention of Bone Loss in Paraplegics Over 2 Years With Alendronate, Journal of Bone and Mineral Research, 2004, 19, 7